Form 4: Abbott Laboratories Executive Daniel Gesua Sive Salvadori Reports Stock Disposal

EVP and Group President of Abbott Laboratories, Daniel Gesua Sive Salvadori, reports disposing of 8,462 common shares to cover tax obligations.

Summary

• On February 28, 2025, Daniel Gesua Sive Salvadori, an Executive Vice President and Group President at Abbott Laboratories, disposed of 8,462 common shares.
• The shares were disposed of at a price of $135.87 per share.
• This transaction was reported on a Form 4 filing with the SEC.
• Following the transaction, Salvadori directly owns 133,769 common shares of Abbott Laboratories.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock disposal, which is a routine event. There is no indication of positive or negative implications for the company's performance.

Industry Context

Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Disposals can occur for various reasons, including tax obligations, diversification, or personal financial planning.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies.
• Form 4 filings are standard practice and are required by the SEC to ensure transparency in insider trading.
• Comparable companies such as Johnson & Johnson (JNJ) and Medtronic (MDT) also have executives who regularly report stock transactions via Form 4 filings.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is a personal transaction of an executive.
• The disposal of shares could slightly increase the available float of Abbott Laboratories stock.

Key Dates